Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 5/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14097649 | 0.93 | ABL1 (0.69) | ABL1 | |
| SCHEMBL14097646 | 0.92 | ABL1 (0.68) | ABL1 | |
| SCHEMBL14097576 | 0.82 | ABL1 (0.76) | ABL1 | |
| SCHEMBL14097438 | 0.81 | ABL1 (0.74) | ABL1 | |
| SCHEMBL14097413 | 0.81 | ABL1 (0.73) | ABL1 | |
| SCHEMBL14097547 | 0.80 | ABL1 (0.86) | ABL1 | |
| SCHEMBL14097642 | 0.77 | ABL1 (0.49) | ABL1 | |
| SCHEMBL14097625 | 0.77 | ABL1 (0.52) | ABL1 | |
| SCHEMBL14097427 | 0.76 | PIK3CA (0.52) | ABL1 | |
| SCHEMBL8998572 | 0.75 | ABL1 (0.50) | ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7414046-B2 | Gyrase inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-08-19 | — | — | US | disclosed |
| US-7414046-B2 | Gyrase inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-08-19 | — | — | US | disclosed |
| US-RE40245-E1 | Gyrase inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-04-15 | — | — | US | disclosed |
| US-RE40245-E1 | Gyrase inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-04-15 | — | — | US | disclosed |
| EP-1341769-B1 | BACTERIAL GYRASE INHIBITORS AND USES THEREOF | VERTEX PHARMA (US) | 2007-10-17 | — | — | EP | disclosed |